Research technician - Cancer Therapeutic Resistance Program (ProCURE)

REF. 26-048_SS_VL

About the research group

The successful candidate will join the ProCURE-OncoBELL research environment at IDIBELL/ICO led by Dr. Alvaro Aytes. The group studies prostate cancer progression and therapy resistance using translational approaches that combine genetically engineered mouse models, organoid and cell culture systems, and molecular and computational analyses. The funded project investigates mechanisms of resistance in castration-resistant prostate cancer and aims to identify therapeutic vulnerabilities with preclinical potential

About the role

IDIBELL is looking for a Research Technician to join a funded translational cancer research project focused on mechanisms of resistance to antiandrogen and immunotherapy treatment in castration-resistant prostate cancer. The selected candidate will support the development of experimental work linked to the project, with a strong emphasis on prostate cancer biology and preclinical models. Duties will include participation in mouse experiments, sample processing, molecular and cellular assays, data collection, and general support to ongoing translational research activities in the laboratory. The candidate is expected to work closely with senior researchers and contribute to high-quality, reproducible research.

Job requirements

Professional experience

• Previous hands-on research experience in prostate cancer research.
• Demonstrated experience working with mouse models in a biomedical research setting, including in vivo experimentation, tissue collection and/or downstream analysis.

Education and training

• Master's degree in Life Sciences, Biomedical Sciences, Biotechnology, Biology, Biochemistry, or a closely related field. A Masters degree will be highly valued.
• Training in cancer biology, translational oncology, animal experimentation, or related areas will be considered essential for the profile. 

Technical & soft skills

• Practical laboratory skills in molecular and cellular biology techniques; ability to work accurately, keep detailed records and follow established protocols.
• Strong organizational skills, motivation for translational cancer research, capacity to work both independently and as part of a multidisciplinary team.

Languages

• Good command of the English language

We will value, but not required

• Experience with organoid cultures, immunohistochemistry, flow cytometry, bioinformatics/data analysis, or FELASA/official accreditation for animal experimentation.

What do we offer

•  No. of positions: 1

•  Estimated start date: 01/06/2026

•  Contract duration: Permannet by project

•  Estimated annual gross salary: It is commensurate with qualifications and consistent with our pay ranges.

•  You will be part of a multicultural team. We have a fun loving and friendly international work environment.

•  Flexible working schedule - We know you have a life outside of work and we will work with you to make sure it's kept that way.

•  Possibility to work some days in remote -Teleworking

•  26 working days of holiday per year

•  System of accumulated hours for employees, from 88 to 104 hours depending on the year (11 to 13 working days), to attend to personal matters.

•  Paid leave package

•  Benefits of constant training are offered

•  We offer and promote diverse and inclusive conditions. Applicants are made free from any discrimination. Specifically IDIBELL works to improve gender equality in all areas with the aim of achieving gender balance, but maintaining the most scrupulous respect to any choice at the level of gender identity. Please express yourself freely, safely and non-binarily, if that's the case.

Deadline: Please submit your application by  06/05/2026

Data protection notice

In compliance with the obligations established in the General Regulation of Data Protection (RGPD), which is the Regulation (EU) 2016/679 of the Parliament and of the Council, of April 27, 2016, and the Organic Law 3/2018, of December 5, Protection of Personal Data and guarantee of digital rights, it is reported that the Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), CIF G58863317, with address Av. Granvia de l'Hospitalet, 199-203, 08908, L'Hospitalet de Llobregat, will process your personal data, as the controller, to apply for the position, maintain communication concerning the status of the candidature, to access the delivered CV; to compare that your data is in accordance with the offers announced by IDIBELL and to verify, where appropriate, that the information provided is accurate. You can find more information in our Privacy Policy at https://idibell.cat/en/privacy-policy-2/, request more information about the data processing carried out and exercise your rights of access, rectification, deletion, opposition, portability, limitation of processing by sending a request at email: dataprotection@idibell.cat. If you consider that you have not obtained satisfaction in exercising your rights, you may submit a claim to Catalan Data Protection Authority.

Our institute

IDIBELL is a research center that integrates the biomedical research of the Bellvitge University Hospital (HUB), the Catalan Institute of Oncology (ICO), and the University of Barcelona in the Bellvitge Campus (UB), and the Viladecans Hospital (HV). The research focuses of IDIBELL are cancer, neuroscience, translational medicine and regenerative medicine. Research, innovation and society are the pivots on which researchers work every day in order to improve the quality of life of citizens.

Observations:

The 'HR Excellence in Research' award represents IDIBELL’s commitment to the implementation of Human Resources policies, which oversee the attracting and development of talent in an open, transparent, and based on personal merit, in alignment with the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment Researchers (Charter and Code).

IDIBELL is committed to the principles of the Code of Conduct for the Recruitment of Researchers of the European Commission and the implementation of open, transparent and merit-based recruitment (OTMR).